Brand record
OZiva: FSSAI and lab-test record
Last checked 1 October 2026
No FSSAI ban, recall or notice against OZiva is on record as of 1 Oct 2026; the Citizens Protein Project 1 (April 2024) detected the fungicides azoxystrobin and dimethomorph in OZiva Protein & Herbs and cautioned on its herbal blend.
- Classification
- Independent lab test finding: Lab-flagged (independent test)
- Tested by
- No regulator action; finding from Citizens Protein Project 1 (published study)
- Reference
- Citizens Protein Project 1 (Medicine, Apr 2024)
- Evidence
- Independent test or study
- Latest action
- 1 April 2024
- Last checked
- 1 October 2026
Photo: Whey Protein Scoop (49935767168).jpg by unknown (CC BY 2.0). All photo credits.
70% of 36 popular protein supplements sold in India mislabeled, 14 contain toxins, says new study
No regulator has acted on this finding. It comes from a published study or a private testing company, and the brand may dispute it.
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe explain what the test or study found. No regulator has acted on it.
Key facts
- Product
- OZiva Protein & Herbs (women's plant protein)
- Pesticide residues detected
- Azoxystrobin, dimethomorph (fungicides)
- Herbal caution
- Study flagged botanical ingredients with hepatotoxic potential; not a test failure
- Regulator action
- None on record
OZiva, the plant-nutrition brand, was tested in the Citizens Protein Project 1. The study, published in Medicine in April 2024, detected two fungicides, azoxystrobin and dimethomorph, in OZiva Protein & Herbs, a pea-and-brown-rice protein sold with a blend of ayurvedic herbs. The paper does not say whether the levels exceeded India's maximum residue limits, so the finding is not described here as a breach.
The study also grouped OZiva's product with other herbal protein blends in a caution note. The authors, several of them liver specialists, pointed to botanical ingredients with a record of hepatotoxicity in case reports. That is an interpretive caution, not a laboratory failure, and it applies to a category rather than to one brand.
No FSSAI recall, prohibition or notice against OZiva is on record, and no company response to the study has been located. The product remains on sale.
What this means for you
Residues were detected; the limit question is open
The paper does not say whether the fungicide levels exceeded a maximum residue limit. Detection alone is not a violation.
Herbs and the liver
The study's authors are hepatologists and flagged several herbal blends. If you have liver disease or take other medicines, mention the product to your doctor.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Sources
News reports
- 70% of 36 popular protein supplements sold in India mislabeled, 14 contain toxins, says new studyNewsThePrint